Compare HMY & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HMY | COO |
|---|---|---|
| Founded | 1950 | 1980 |
| Country | South Africa | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Ophthalmic Goods |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.9B | 15.9B |
| IPO Year | N/A | N/A |
| Metric | HMY | COO |
|---|---|---|
| Price | $21.23 | $81.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 11 |
| Target Price | $16.00 | ★ $89.73 |
| AVG Volume (30 Days) | ★ 4.5M | 2.1M |
| Earning Date | 02-04-2016 | 03-05-2026 |
| Dividend Yield | ★ 0.68% | N/A |
| EPS Growth | ★ 67.74 | N/A |
| EPS | 1.29 | ★ 1.87 |
| Revenue | ★ $4,161,584,110.00 | $4,092,400,000.00 |
| Revenue This Year | $40.10 | $6.59 |
| Revenue Next Year | $14.83 | $5.39 |
| P/E Ratio | ★ $19.43 | $42.98 |
| Revenue Growth | ★ 20.39 | 5.06 |
| 52 Week Low | $9.69 | $61.78 |
| 52 Week High | $26.06 | $99.54 |
| Indicator | HMY | COO |
|---|---|---|
| Relative Strength Index (RSI) | 46.18 | 49.91 |
| Support Level | $23.04 | $79.61 |
| Resistance Level | $26.04 | $83.79 |
| Average True Range (ATR) | 1.22 | 1.53 |
| MACD | 0.00 | -0.37 |
| Stochastic Oscillator | 4.46 | 35.62 |
Harmony Gold Mining Co Ltd is engaged in gold mining and related activities, including exploration, extraction, and processing. The group's primary product is gold bullion, produced at operations in South Africa and Papua New Guinea. Gold byproducts include uranium and silver. Strategic projects such as the Wafi-Golpu Project in the New Guinea Mobile Belt, the Eva Copper Project in the Mt Isa Inlier, Queensland, Australia, and the MAC Copper acquisition position the company as a gold-copper producer. The company operates across South Africa, Papua New Guinea, and Australia.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.